Opportunities Preloader

Please Wait.....

Report

North America Biological Buffers Market

Market Report I 2025-03-01 I 350 Pages I Data Bridge Market Research

The North America biological buffers market is expected to reach USD 754 million by 2035 from USD 336.25 million in 2024, growing at a substantial CAGR of 7.7% in the forecast period of 2025 to 2035.
Market Segmentation:
Buffers Type (Goods Buffers, Other Salt-Based Buffers), Formulation (Powder, Liquid), Application (Pharmaceutical & Biopharmaceuticals, Cell Culture & Molecular Biology, Clinical & Diagnostic Applications, Chemical & Industrial Applications, Others), End User (Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Research & Academic Institutes, Diagnostic Laboratories, Contract Research Organizations (CROs) & CMOs), Country (U.S., Canada, Mexico)

Overview of North America Biological Buffers Market Dynamics:

Driver

Rising Prevalence of Chronic Diseases
Restrain

Limited Shelf Life of Blocking Buffers

Opportunity

Increase In Public-Private Funding in Biomedical Research
Market Players:

The key market players operating in the North America Biological Buffers market are listed below:

- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Takara Bio Inc.
- Merck KGaA
- Avantor, Inc.
- Advancion Corporation
- Santa Cruz Biotechnology Inc.
- MP Biomedicals
- Promega Corporation
- Beckman Coulter, Inc.
- QIAGEN
- Cayman Chemical
- FUJIFILM Wako Pure Chemical Corporation
- GoldBio

TABLE OF CONTENTS
1 INTRODUCTION 53
1.1 OBJECTIVES OF THE STUDY 53
1.2 MARKET DEFINITION 53
1.3 OVERVIEW OF THE NORTH AMERICA BIOLOGICAL BUFFERS MARKET 53
1.4 LIMITATIONS 54
1.5 MARKETS COVERED 54
2 MARKET SEGMENTATION 58
2.1 MARKETS COVERED 58
2.2 GEOGRAPHICAL SCOPE 59
2.3 YEARS CONSIDERED FOR THE STUDY 60
2.4 CURRENCY AND PRICING 60
2.5 DBMR TRIPOD DATA VALIDATION MODEL 61
2.6 MULTIVARIATE MODELLING 64
2.7 TYPE LIFELINE CURVE 64
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 65
2.9 DBMR MARKET POSITION GRID 66
2.10 MARKET END USER COVERAGE GRID 67
2.11 VENDOR SHARE ANALYSIS 68
2.12 SECONDARY SOURCES 69
2.13 ASSUMPTIONS 69
3 EXECUTIVE SUMMARY 70
4 PREMIUM INSIGHTS 72
5 NORTH AMERICA BIOLOGICAL BUFFER MARKET: REGULATIONS 76
5.1 REGULATORY AUTHORITIES IN THE U.S. 76
5.2 REGULATORY SUBMISSIONS 83
5.3 INTERNATIONAL HARMONIZATION 83
5.4 EUROPE REGULATORY SCENARIO 84
5.5 REGULATORY SUBMISSIONS 86
5.6 INTERNATIONAL HARMONIZATION 87
5.7 JAPAN REGULATORY SCENARIO 89
5.8 REGULATORY SUBMISSIONS 91
5.9 INTERNATIONAL HARMONIZATION 92
5.10 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS 93
6 MARKET OVERVIEW 96
6.1 DRIVERS 98
6.1.1 RISING PREVALENCE OF CHRONIC DISEASES 98
6.1.2 INCREASED ADOPTION OF WESTERN BLOT AND ELISA TECHNIQUES 98
6.1.3 TECHNOLOGICAL ADVANCEMENTS IN ASSAY DEVELOPMENT 99
6.1.4 ADVANCEMENTS IN PROTEOMICS AND GENOMICS 100
6.2 RESTRAINTS 101
6.2.1 LIMITED SHELF LIFE OF BLOCKING BUFFERS 101
6.2.2 POTENTIAL OF CONTAMINATION OR BATCH INCONSISTENCIES FOR BIOLOGICAL BUFFERS 101
6.3 OPPORTUNITY 102
6.3.1 INCREASE IN PUBLIC-PRIVATE FUNDING IN BIOMEDICAL RESEARCH 102
6.3.2 ANALYTICAL METHODS FOR FOOD SAFETY AND ENVIRONMENTAL TESTING. 103
6.3.3 DIAGNOSTIC AND CLINICAL APPLICATIONS USE BLOCKING BUFFERS. 103
6.4 CHALLENGES 104
6.4.1 ALTERNATIVE TECHNOLOGIES AND APPROACHES FOR INHIBITING BIOLOGICAL BUFFERS. 104
6.4.2 DISRUPTIONS IN THE SUPPLY CHAIN OF BIOLOGICAL BUFFERS. 105
7 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY BUFFERS TYPE 106
7.1 OVERVIEW 107
7.2 GOODS BUFFERS 110
7.2.1 TRIS BUFFERS 111
7.2.2 HEPES BUFFERS 112
7.2.3 MOPS BUFFERS 113
7.2.4 MES BUFFERS 113
7.2.5 BIS-TRIS BUFFERS 114
7.3 OTHER SALT-BASED BUFFERS 115
7.3.1 PHOSPHATE BUFFERS 116
7.3.2 ACETATE BUFFERS 117
7.3.3 CITRATE BUFFERS 117
7.3.4 AMINO ACID BUFFERS 117
8 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY FORMULATION 119
8.1 OVERVIEW 120
8.2 POWDER 123
8.3 LIQUID 124
9 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY APPLICATION 125
9.1 OVERVIEW 126
9.2 PHARMACEUTICAL & BIOPHARMACEUTICALS 129
9.3 CELL CULTURE & MOLECULAR BIOLOGY 131
9.4 CLINICAL & DIAGNOSTIC APPLICATIONS 133
9.5 CHEMICAL & INDUSTRIAL APPLICATIONS 135
9.6 OTHERS 136
10 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY END USER 137
10.1 OVERVIEW 138
10.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 142
10.3 BIOTECHNOLOGY COMPANIES 143
10.4 RESEARCH & ACADEMIC INSTITUTES 144
10.5 DIAGNOSTIC LABORATORIES 145
10.6 CONTRACT RESEARCH ORGANIZATIONS (CROS) & CMOS 146
11 NORTH AMERICA BIOLOGICAL BUFFERS MARKET, BY REGION 147
11.1 NORTH AMERICA 149
11.1.1 U.S 158
11.1.2 CANADA 167
11.1.3 MEXICO 176
12 NORTH AMERICA BIOLOGICAL BUFFERS MARKET: COMPANY LANDSCAPE 184
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 184
13 SWOT 185
14 COMPANY PROFILES 186
14.1 F. HOFFMANN-LA ROCHE LTD 186
14.1.1 COMPANY SNAPSHOT 186
14.1.2 REVENUE ANALYSIS 186
14.1.3 COMPANY SHARE ANALYSIS 187
14.1.4 PRODUCT PORTFOLIO 187
14.1.5 RECENT UPDATES 188
14.2 BIO-RAD LABORATORIES, INC. 189
14.2.1 COMPANY SNAPSHOT 189
14.2.2 REVENUE ANALYSIS 189
14.2.3 COMPANY SHARE ANALYSIS 190
14.2.4 PRODUCT PORTFOLIO 190
14.2.5 RECENT DEVELOPMENT 190
14.3 THERMO FISHER SCIENTIFIC, INC. 191
14.3.1 COMPANY SNAPSHOT 191
14.3.2 REVENUE ANALYSIS 191
14.3.3 COMPANY SHARE ANALYSIS 192
14.3.4 PRODUCT PORTFOLIO 192
14.3.5 RECENT UPDATES 196
14.4 TAKARA BIO INC. 197
14.4.1 COMPANY SNAPSHOT 197
14.4.2 REVENUE ANALYSIS 197
14.4.3 COMPANY SHARE ANALYSIS 198
14.4.4 PRODUCT PORTFOLIO 198
14.4.5 RECENT DEVELOPMENTS 199
14.5 MERCK KGAA, DARMSTADT, GERMANY 200
14.5.1 COMPANY SNAPSHOT 200
14.5.2 REVENUE ANALYSIS 200
14.5.3 COMPANY SHARE ANALYSIS 201
14.5.4 PRODUCT PORTFOLIO 201
14.5.5 RECENT DEVELOPMENTS 201
14.6 ADVANCION CORPORATION 203
14.6.1 COMPANY SNAPSHOT 203
14.6.2 PRODUCT PORTFOLIO 203
14.6.3 RECENT DEVELOPMENT 204
14.7 AVANTOR, INC. 205
14.7.1 COMPANY SNAPSHOT 205
14.7.2 REVENUE ANALYSIS 205
14.7.3 PRODUCT PORTFOLIO 206
14.7.4 RECENT DEVELOPMENT 207
14.8 BECKMAN COULTER 208
14.8.1 COMPANY SNAPSHOT 208
14.8.2 PRODUCT PORTFOLIO 208
14.8.3 RECENT DEVELOPMENT 208
14.9 BIOSYNTH 209
14.9.1 COMPANY SNAPSHOT 209
14.9.2 PRODUCT PORTFOLIO 209
14.9.3 RECENT DEVELOPMENT 210
14.10 FUJIFILM WAKO PURE CHEMICAL CORPORATION 211
14.10.1 COMPANY SNAPSHOT 211
14.10.2 PRODUCT PORTFOLIO 211
14.10.3 RECENT DEVELOPMENT 213
14.11 GOLDBIO 214
14.11.1 COMPANY SNAPSHOT 214
14.11.2 PRODUCT PORTFOLIO 214
14.11.3 RECENT DEVELOPMENT 216
14.12 HOPAX 217
14.12.1 COMPANY SNAPSHOT 217
14.12.2 PRODUCT PORTFOLIO 217
14.12.3 RECENT DEVELOPMENT 219
14.13 HIMEDIA LABORATORIES 220
14.13.1 COMPANY SNAPSHOT 220
14.13.2 PRODUCT PORTFOLIO 220
14.13.3 RECENT DEVELOPMENT 221
14.14 MP BIOMEDICALS. 222
14.14.1 COMPANY SNAPSHOT 222
14.14.2 PRODUCT PORTFOLIO 222
14.14.3 RECENT DEVELOPMENT 223
14.15 NACALAI TESQUE, INC. 224
14.15.1 COMPANY SNAPSHOT 224
14.15.2 PRODUCT PORTFOLIO 224
14.15.3 RECENT DEVELOPMENT 226
14.16 PROMEGA CORPORATION 228
14.16.1 COMPANY SNAPSHOT 228
14.16.2 PRODUCT PORTFOLIO 228
14.16.3 RECENT DEVELOPMENT 229
14.17 QIAGEN 230
14.17.1 COMPANY SNAPSHOT 230
14.17.2 REVENUE ANALYSIS 230
14.17.3 PRODUCT PORTFOLIO 231
14.17.4 RECENT DEVELOPMENT 231
14.18 REAGECON DIAGNOSTICS LTD 232
14.18.1 COMPANY SNAPSHOT 232
14.18.2 PRODUCT PORTFOLIO 232
14.18.3 RECENT DEVELOPMENT 234
14.19 SANTA CRUZ BIOTECHNOLOGY INC. 235
14.19.1 COMPANY SNAPSHOT 235
14.19.2 PRODUCT PORTFOLIO 235
14.19.3 RECENT DEVELOPMENT 237
14.20 SERVA ELECTROPHORESIS GMBH 238
14.20.1 COMPANY SNAPSHOT 238
14.20.2 PRODUCT PORTFOLIO 238
14.20.3 RECENT DEVELOPMENT 238
14.21 TEVA PHARMACEUTICALS USA, INC. 239
14.21.1 COMPANY SNAPSHOT 239
14.21.2 REVENUE ANALYSIS 239
14.21.3 PRODUCT PORTFOLIO 240
14.21.4 RECENT DEVELOPMENT 241
15 QUESTIONNAIRE 242
16 RELATED REPORTS 245
?

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE